AI-BOOST AFFINITY
DEAD

Serial Number

79414786

Owner

ProteoGenix

Filing Date

Oct 4, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AI-BOOST AFFINITY Trademark

Serial Number: 79414786

AI-BOOST AFFINITY is a trademark filed by ProteoGenix on October 4, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ProteoGenix (3 trademarks)

19 Rue de la Haye

Entity Type: 92

Trademark Details

Filing Date

October 4, 2024

Registration Date

Not Registered

Goods & Services

Computer software used in the context of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; computer software used in the context of antibody discovery and identification; artificial intelligence software used in the context of drug discovery, affinity maturation, engineering of biological products, studies of molecular interactions, humanization and identification, drug research, antibody research and design, pharmaceutical research; machine learning software used in the context of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; downloadable software for research, diagnostics, genomics, proteomics, omics and biological products; big data generating software.

Software as a service [SaaS] for a use in the field of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; medicine discovery services; biological research; scientific services and research in the field of drug discovery, affinity maturation, biological product engineering, studies of molecular interactions, humanization and identification, drug research, antibody, protein, peptide, biological and chemical research and design, pharmaceutical research; antibody sequencing; Research and development services related to AI in the field of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; research and development in the field of drug discovery and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals; research and development services in the field of antibody technology; electronic data storage; Software as a Service [SaaS] including software for machine learning.

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Oct 10, 2025 DETH
REFUSAL PROCESSED BY IB
Jun 13, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 24, 2025 RFCS
REFUSAL PROCESSED BY MPU
May 24, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 27, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 26, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 20, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 17, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 16, 2025 REPR